Author:
Emmenegger Urban,Spaeth Peter J.,Neftel Klaus A.,Imashuku Shinsaku,Teramura Tomoko,Ishii Eiichi,Kinugawa Naoko,Kato Masahiko,Sako Masahiro,Kuriyama Kikuko,Hibi Shigeyoshi
Publisher
American Society of Clinical Oncology (ASCO)
Reference11 articles.
1. Requirement for Etoposide in the Treatment of Epstein-Barr Virus–Associated Hemophagocytic Lymphohistiocytosis
2. Hyperferritinemia as indicator for intravenous immunoglobulin treatment in reactive macrophage activation syndromes
3. Larroche C, Bruneel F, André MH, et al: [Intravenously administered gamma-globulins in reactive hemaphagocytic syndrome: Multicenter study to assess their importance, by the immunoglobulins group of experts of CEDIT of the AP-HP]. Ann Med Interne 151: 533,2000–539,
4. Treatment Strategies for Epstein-Barr Virus-Associated Hemophagocytic Lymphohistiocytosis (EBV-HLH)
5. Kaito K, Kobayashi M, Katayama T, et al: Prognostic factors of hemophagocytic syndrome in adults: Analysis of 34 cases. Eur J Haematol 59: 247,1997–253,
Cited by
40 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献